7 research outputs found

    Disease stabilization (SD) as a surrogate end-point in advanced non-small-cell lung cancer (NSCLC) patients treated with erlotinib (E) or gefitinib (G)

    Get PDF
    none7noGrossi, F; Defferrari, C; Brianti, A; Dal Bello, Mg; Loprevite, M; Catania, G; Pronzato, PGrossi, F; Defferrari, C; Brianti, A; Dal Bello, Mg; Loprevite, M; Catania, Gianluca; Pronzato, P

    Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial

    No full text
    corecore